Amalgamated Financial (AMAL) Research & Development (2020 - 2026)

Amalgamated Financial's Research & Development history runs 7 years deep, the most recent figure standing at $6.6 million for Q1 2026.

• On a quarterly basis, Research & Development rose 17.78% year-over-year to $6.6 million in Q1 2026; TTM through Mar 2026 was $25.1 million, a 20.61% increase from a year earlier, with the FY2025 full-year figure at $24.1 million, up 21.58% from the prior year.
• Research & Development retreated to $6.6 million in Q1 2026 per AMAL's latest filing, from $7.0 million in the prior quarter.
• Across five years, Research & Development topped out at $7.0 million in Q4 2025 and bottomed at $4.1 million in Q4 2022.
• The 5-year median for Research & Development is $4.8 million (2024), against an average of $5.1 million.
• Biggest YoY gain for Research & Development was 72.51% in 2022; the steepest drop was 21.6% in 2022.
• Year by year, Research & Development stood at $4.1 million in 2022, then rose by 12.18% to $4.6 million in 2023, then gained by 16.0% to $5.3 million in 2024, then surged by 31.93% to $7.0 million in 2025, then slipped by 5.34% to $6.6 million in 2026.
• Per Business Quant, the three latest AMAL Research & Development figures stand at $6.6 million (Q1 2026), $7.0 million (Q4 2025), and $6.0 million (Q3 2025).